UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells

Signal transduction and targeted therapy, 2021-07, Vol.6 (1), p.286-286, Article 286

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy

Clinical cancer research, 2018-07, Vol.24 (14), p.3325-3333

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment

Frontiers in immunology, 2023, Vol.14, p.1283186-1283186

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006464

2023

Link zum Volltext

Verfügbarkeit prüfen

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

Proceedings of the National Academy of Sciences - PNAS, 2008-11, Vol.105 (45), p.17481-17486

2008

Link zum Volltext

Verfügbarkeit prüfen

safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer

Proceedings of the National Academy of Sciences - PNAS, 2008-01, Vol.105 (2), p.623-628

2008

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies

Frontiers in immunology, 2024, Vol.15, p.1352615-1352615

2024

Link zum Volltext

Verfügbarkeit prüfen

Preventing tumor escape by targeting a post-proteasomal trimming independent epitope

The Journal of experimental medicine, 2016-10, Vol.213 (11), p.2333-2348

2016

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

Journal of translational medicine, 2010-06, Vol.8 (1), p.53-53, Article 53

2010

Link zum Volltext

Verfügbarkeit prüfen

Correction: Preventing tumor escape by targeting a post-proteasomal trimming independent epitope

The Journal of experimental medicine, 2017-02, Vol.214 (2), p.567-567

2017

Link zum Volltext

Verfügbarkeit prüfen

930 Fibroblast activation protein alpha expression in tumor stroma and its association with immuno-regulatory circuits across epithelial tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A976-A976

2021

Link zum Volltext

Verfügbarkeit prüfen

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines

International journal of cancer, 2004-01, Vol.108 (1), p.71-77

2004

Link zum Volltext

Verfügbarkeit prüfen

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

Cancer Immunology, Immunotherapy, 2009-05, Vol.58 (5), p.653-664

2009

Link zum Volltext

Verfügbarkeit prüfen

Protective Efficacy of a DNA Influenza Virus Vaccine Is Markedly Increased by the Coadministration of a Schiff Base-Forming Drug

Journal of Virology, 2004-10, Vol.78 (20), p.11321-11326

2004

Link zum Volltext

Verfügbarkeit prüfen

Targeting of Human Dendritic Cells by Autologous NK Cells

The Journal of immunology (1950), 1999-12, Vol.163 (12), p.6365-6370

1999

Link zum Volltext

Verfügbarkeit prüfen

Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine

The Prostate, 2005-02, Vol.62 (3), p.217-223

2005

Link zum Volltext

Verfügbarkeit prüfen

Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine production

Journal of leukocyte biology, 2007-05, Vol.81 (5), p.1297-1302

2007

Link zum Volltext

Verfügbarkeit prüfen

Biomarker Technologies to Support Early Clinical Immuno-oncology Development: Advances and Interpretation

Clinical cancer research, 2021-08, Vol.27 (15), p.4147-4159

2021

Link zum Volltext

Verfügbarkeit prüfen

A Composite Decision Rule of CD8+ T-cell Density in Tumor Biopsies Predicts Efficacy in Early-stage, Immunotherapy Trials

Clinical cancer research, 2024-02, Vol.30 (4), p.877

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5464: Predictive biomarkers for PD-1 and PD-L1 checkpoint inhibitor response in NSCLC: An analysis of clinical trial and real-world data

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5464-5464

2023

Link zum Volltext

Verfügbarkeit prüfen

Systemic Immune Response to a CD40-Agonist Antibody in Nonhuman Primates

Journal of leukocyte biology, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy

Journal for immunotherapy of cancer, 2023-01, Vol.11 (1), p.e005514

2023

Link zum Volltext

Verfügbarkeit prüfen

NK Cell Triggering by the Human Costimulatory Molecules CD80 and CD86

The Journal of immunology (1950), 1999-10, Vol.163 (8), p.4207-4212

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(54)
Berichte
(1)

Sprache

Englisch
(55)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(39)
Humans
(30)
Animals
(26)
Mice
(22)
Immunology
(21)
Medicin Och Hälsovetenskap
(19)
Immunotherapy
(14)
Oncology
(13)
Mice, Inbred C57bl
(12)
T-Lymphocytes - Immunology
(12)
Tumors
(12)
Biological And Medical Sciences
(11)
Female
(11)
Medical Sciences
(8)
Mice, Transgenic
(8)
Cancer
(7)
T-Lymphocytes, Cytotoxic - Immunology
(7)
Killer Cells, Natural - Immunology
(6)
Male
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells

Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy

Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment

Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data

Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer

Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies

Preventing tumor escape by targeting a post-proteasomal trimming independent epitope

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

Correction: Preventing tumor escape by targeting a post-proteasomal trimming independent epitope

930 Fibroblast activation protein alpha expression in tumor stroma and its association with immuno-regulatory circuits across epithelial tumors

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

Protective Efficacy of a DNA Influenza Virus Vaccine Is Markedly Increased by the Coadministration of a Schiff Base-Forming Drug

Targeting of Human Dendritic Cells by Autologous NK Cells

Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine

Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine production

Biomarker Technologies to Support Early Clinical Immuno-oncology Development: Advances and Interpretation

A Composite Decision Rule of CD8+ T-cell Density in Tumor Biopsies Predicts Efficacy in Early-stage, Immunotherapy Trials

Abstract 5464: Predictive biomarkers for PD-1 and PD-L1 checkpoint inhibitor response in NSCLC: An analysis of clinical trial and real-world data

Systemic Immune Response to a CD40-Agonist Antibody in Nonhuman Primates

Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy

NK Cell Triggering by the Human Costimulatory Molecules CD80 and CD86

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

Suchergebnisse filtern